Alterego Ventures 24 Corp. — Regulatory Filings 2020

Jan 31, 2020

January 28, 2020

Alberta Securities Commission British Columbia Securities Commission Ontario Securities Commission TSX Venture Exchange

Dear Sirs/Mesdames:

Re: A-LABS CAPITAL V CORP. (the "Company") Final Prospectus dated January 28, 2020

We refer to the final prospectus of Company dated January 28, 2020 qualifying the distribution of a minimum of 2,500,000 and a maximum of 5,000,000 common shares of the Company at a price of $0.10 per common share (the "Prospectus").

We consent to being named in and to the use in the above-mentioned Prospectus, of our report dated January 28, 2020 to the directors of the Company on the following financial statements:

• statement of financial position as at October 31, 2019;

• statements of loss and comprehensive loss, changes in equity and cash flows for the period from date of incorporation (November 29, 2018) to October 31, 2019, and a summary of significant accounting policies and other explanatory information.

We report that we have read the Prospectus and have no reason to believe that there are any misrepresentations in the information contained therein that are derived from the financial statements upon which we have reported or that are within our knowledge as a result of our audit of such financial statements. We have complied with Canadian generally accepted standards for an auditor’s consent to the use of a report of the auditor including in an offering document, which does not constitute an audit or review of the Prospectus as these terms are described in the CPA Canada Handbook – Assurance.

Yours very truly,

RSM Canada LLP Chartered Professional Accountants Licensed Public Accountants Toronto, Ontario